Drug Enforcement Administration – Federal Register Recent Federal Regulation Documents

Results 1 - 50 of 3,716
Designation of 3,4-MDP-2-P methyl glycidate (PMK glycidate), 3,4-MDP-2-P methyl glycidic acid (PMK glycidic acid), and alpha-phenylacetoacetamide (APAA) as List I Chemicals
Document Number: 2021-09697
Type: Rule
Date: 2021-05-10
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration is finalizing a December 21, 2020, notice of proposed rulemaking to designate three chemicals, known as PMK glycidate, PMK glycidic acid, and APAA, as list I chemicals under the Controlled Substances Act (CSA). PMK glycidate and PMK glycidic acid are used in and are important to the manufacture of the schedule I controlled substance 3,4-methylenedioxymethamphetamine (MDMA) and other ``ecstasy''-type substances, and APAA is used in and is important to the manufacture of the schedule II controlled substances amphetamine and methamphetamine. This final rulemaking subjects handlers (manufacturers, distributors, importers, and exporters) of PMK glycidate, PMK glycidic acid, and APAA to the chemical regulatory provisions of the CSA and its implementing regulations.
Schedules of Controlled Substances: Placement of Serdexmethylphenidate in Schedule IV
Document Number: 2021-09738
Type: Rule
Date: 2021-05-07
Agency: Drug Enforcement Administration, Department of Justice
On March 2, 2021, the United States Food and Drug Administration approved a new drug application for AZSTARYS capsules for oral use, a combination drug product containing serdexmethylphenidate chloride and dexmethylphenidate hydrochloride, for the treatment of Attention Deficit Hyperactivity Disorder in patients six years of age or older. The Department of Health and Human Services provided the Drug Enforcement Administration with a scheduling recommendation to place serdexmethylphenidate and its salts in schedule IV of the Controlled Substances Act. In accordance with the Controlled Substances Act, as amended by the Improving Regulatory Transparency for New Medical Therapies Act, Drug Enforcement Administration is hereby issuing an interim final rule placing serdexmethylphenidate, including its salts, isomers, and salts of isomers, in schedule IV of the Controlled Substances Act, thereby facilitating the commercial distribution of AZSTARYS as a lawful controlled substance.
Bulk Manufacturer of Controlled Substances Application: Bulk Manufacturer of Marihuana: Green Rush Organic Farms Inc.
Document Number: 2021-09663
Type: Notice
Date: 2021-05-07
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) is providing notice of an application it has received from an entity applying to be registered to manufacture in bulk basic class(es) of controlled substances listed in schedule I. DEA intends to evaluate this and other pending applications according to its regulations governing the program of growing marihuana for scientific and medical research under DEA registration.
Bulk Manufacturer of Controlled Substances Application: Bulk Manufacturer of Marihuana: Indian Flower LLC
Document Number: 2021-09662
Type: Notice
Date: 2021-05-07
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) is providing notice of an application it has received from an entity applying to be registered to manufacture in bulk basic class(es) of controlled substances listed in schedule I. DEA intends to evaluate this and other pending applications according to its regulations governing the program of growing marihuana for scientific and medical research under DEA registration.
Michele L. Martinho, M.D.; Decision and Order
Document Number: 2021-09464
Type: Notice
Date: 2021-05-05
Agency: Drug Enforcement Administration, Department of Justice
Melanie Baker, N.P.; Decision and Order
Document Number: 2021-09463
Type: Notice
Date: 2021-05-05
Agency: Drug Enforcement Administration, Department of Justice
Emmanuel A. Ayodele, M.D.; Decision and Order
Document Number: 2021-09461
Type: Notice
Date: 2021-05-05
Agency: Drug Enforcement Administration, Department of Justice
Schedules of Controlled Substances: Placement of Four Specific Fentanyl-Related Substances in Schedule I
Document Number: 2021-09402
Type: Rule
Date: 2021-05-04
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration places four specified fentanyl-related substances permanently in schedule I of the Controlled Substances Act. These four specific substances fall within the definition of fentanyl-related substances set forth in the February 6, 2018, temporary scheduling order. Through the Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act, which became law on February 6, 2020, Congress extended the temporary control of fentanyl-related substances until May 6, 2021. The regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle any of these four specified fentanyl-related substances will continue to be applicable permanently as a result of this action.
Importer of Controlled Substances Application: VHG Labs DBA LGC Standards
Document Number: 2021-09302
Type: Notice
Date: 2021-05-04
Agency: Drug Enforcement Administration, Department of Justice
VHG Labs DBA LGC Standards has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Cargill, Incorporated
Document Number: 2021-09301
Type: Notice
Date: 2021-05-04
Agency: Drug Enforcement Administration, Department of Justice
Cargill, Inc., has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.
Importer of Controlled Substances Application: Wildlife Laboratories, LLC
Document Number: 2021-09300
Type: Notice
Date: 2021-05-04
Agency: Drug Enforcement Administration, Department of Justice
Wildlife Laboratories, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.
Schedules of Controlled Substances: Placement of 10 Specific Fentanyl-Related Substances in Schedule I
Document Number: 2021-08720
Type: Rule
Date: 2021-04-27
Agency: Drug Enforcement Administration, Department of Justice
In this rule, the Drug Enforcement Administration places 10 specified fentanyl-related substances permanently in schedule I of the Controlled Substances Act. These 10 specific substances all fall within the definition of fentanyl-related substances set forth in a February 6, 2018, temporary scheduling order. Through the Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act, which became law on February 6, 2020, Congress extended the temporary control of fentanyl-related substances until May 6, 2021. The regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle any of these 10 specified fentanyl-related substances will continue to be applicable permanently as a result of this action.
Agency Information Collection Activities; Proposed eCollection, eComments Requested; New Proposed Collection Exempt Chemical Preparations Application
Document Number: 2021-08586
Type: Notice
Date: 2021-04-26
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA), Department of Justice (DOJ), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Importer of Controlled Substances Application: Rhodes Technologies
Document Number: 2021-08539
Type: Notice
Date: 2021-04-26
Agency: Drug Enforcement Administration, Department of Justice
Rhodes Technologies has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Rhodes Technologies
Document Number: 2021-08544
Type: Notice
Date: 2021-04-23
Agency: Drug Enforcement Administration, Department of Justice
Rhodes Technologies has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Cardinal Health
Document Number: 2021-08537
Type: Notice
Date: 2021-04-23
Agency: Drug Enforcement Administration, Department of Justice
Cardinal Health has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.
Importer of Controlled Substances Application: Lipomed
Document Number: 2021-08535
Type: Notice
Date: 2021-04-23
Agency: Drug Enforcement Administration, Department of Justice
Lipomed has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.
Exempt Chemical Preparations Under the Controlled Substances Act
Document Number: 2021-06689
Type: Notice
Date: 2021-04-23
Agency: Drug Enforcement Administration, Department of Justice
The applications for exempt chemical preparations received by the Drug Enforcement Administration (DEA) between July 1, 2018, and December 31, 2020, as listed below, were accepted for filing and have been approved or denied as indicated.
Javaid A. Perwaiz, M.D.; Decision and Order
Document Number: 2021-08173
Type: Notice
Date: 2021-04-21
Agency: Drug Enforcement Administration, Department of Justice
Mark A. Wimbley, M.D.; Decision and Order
Document Number: 2021-08171
Type: Notice
Date: 2021-04-21
Agency: Drug Enforcement Administration, Department of Justice
Michael Jones, M.D.; Decision and Order
Document Number: 2021-08169
Type: Notice
Date: 2021-04-21
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Research Triangle Institute
Document Number: 2021-08166
Type: Notice
Date: 2021-04-21
Agency: Drug Enforcement Administration, Department of Justice
Research Triangle Institute has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Research Triangle Institute
Document Number: 2021-08165
Type: Notice
Date: 2021-04-21
Agency: Drug Enforcement Administration, Department of Justice
Research Triangle Institute, has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Scottsdale Research Institute
Document Number: 2021-08162
Type: Notice
Date: 2021-04-21
Agency: Drug Enforcement Administration, Department of Justice
Scottsdale Research Institute has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.
The Pharmacy Place Order
Document Number: 2021-08018
Type: Notice
Date: 2021-04-21
Agency: Drug Enforcement Administration, Department of Justice
Schedules of Controlled Substances: Removal of Samidorphan From Control
Document Number: 2021-07884
Type: Rule
Date: 2021-04-19
Agency: Drug Enforcement Administration, Department of Justice
With the issuance of this final rule, the Acting Administrator of the Drug Enforcement Administration removes samidorphan (3- carboxamido-4-hydroxy naltrexone) and its salts from the schedules of the Controlled Substances Act. This scheduling action is pursuant to the Controlled Substances Act which requires that such actions be made on the record after opportunity for a hearing through formal rulemaking. Prior to the effective date of this rule, samidorphan was a schedule II controlled substance because it can be derived from opium alkaloids. This action removes the regulatory controls and administrative, civil, and criminal sanctions applicable to controlled substances, including those specific to schedule II controlled substances, on persons who handle (manufacture, distribute, reverse distribute, dispense, conduct research, import, export, or conduct chemical analysis) or propose to handle samidorphan.
Jennifer L. St. Croix, M.D.; Decision and Order
Document Number: 2021-07410
Type: Notice
Date: 2021-04-12
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Royal Emerald Pharmaceuticals Research and Development DBA: Royal Emerald Pharmaceuticals
Document Number: 2021-06900
Type: Notice
Date: 2021-04-05
Agency: Drug Enforcement Administration, Department of Justice
Royal Emerald Pharmaceuticals Research and Development DBA: Royal Emerald Pharmaceuticals has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.
Brenton D. Goodman, M.D.; Decision and Order
Document Number: 2021-06801
Type: Notice
Date: 2021-04-02
Agency: Drug Enforcement Administration, Department of Justice
Kendrick E. Duldulao, M.D.; Decision and Order
Document Number: 2021-06799
Type: Notice
Date: 2021-04-02
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Bulk Manufacturer of Marihuana: ThinkPur, LLC
Document Number: 2021-06688
Type: Notice
Date: 2021-04-01
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) is providing notice of an application it has received from an entity applying to be registered to manufacture in bulk basic class(es) of controlled substances listed in schedule I. DEA intends to evaluate this and other pending applications according to its regulations governing the program of growing marihuana for scientific and medical research under DEA registration.
Importer of Controlled Substances Application: Sharp Clinical Services, Inc.
Document Number: 2021-06687
Type: Notice
Date: 2021-04-01
Agency: Drug Enforcement Administration, Department of Justice
Sharp Clinical Services, Inc., has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.
Schedules of Controlled Substances: Placement of cyclopentyl fentanyl, isobutyryl fentanyl, para-chloroisobutyryl fentanyl, para-methoxybutyryl fentanyl, and valeryl fentanyl in Schedule I; Correction
Document Number: 2021-06596
Type: Rule
Date: 2021-03-31
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration is correcting a final rule that appeared in the Federal Register on November 25, 2020. The document issued an action placing five fentanyl-related substances (cyclopentyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- phenylcyclopentanecarboxamide), isobutyryl fentanyl (N-(1- phenethylpiperidin-4-yl)-N-phenylisobutyramide), para-chloroisobutyryl fentanyl (N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4- yl)isobutyramide), para-methoxybutyryl fentanyl (N-(4-methoxyphenyl)-N- (1-phenethylpiperidin-4-yl)butyramide), and valeryl fentanyl (N-(1- phenethylpiperidin-4-yl)-N-phenylpentanamide), including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, permanently in schedule I of the Controlled Substances Act, specifically to the opiates list under DEA regulations. The published document assigned incorrect paragraph numbers to all five substances, and inadvertently removed four other substances from the listed opiates.
Roozbeh Badii, M.D.; Decision and Order
Document Number: 2021-06584
Type: Notice
Date: 2021-03-31
Agency: Drug Enforcement Administration, Department of Justice
Ester Mark, M.D.; Decision and Order
Document Number: 2021-06583
Type: Notice
Date: 2021-03-31
Agency: Drug Enforcement Administration, Department of Justice
Eric R. Shibley, M.D.; Decision and Order
Document Number: 2021-06582
Type: Notice
Date: 2021-03-31
Agency: Drug Enforcement Administration, Department of Justice
Schedules of Controlled Substances: Extension of Temporary Placement of 5F-EDMB-PINACA, 5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA and FUB-144 in Schedule I of the Controlled Substances Act
Document Number: 2021-06555
Type: Rule
Date: 2021-03-31
Agency: Drug Enforcement Administration, Department of Justice
The Acting Administrator of the Drug Enforcement Administration is issuing this order to extend the temporary schedule I status of ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3- dimethylbutanoate (trivial name: 5F-EDMB-PINACA); methyl 2-(1-(5- fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (trivial name: 5F-MDMB-PICA); N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole- 3-carboxamide (trivial names: FUB-AKB48; FUB-APINACA; AKB48 N-(4- fluorobenzyl)); 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole- 3-carboxamide (trivial names: 5F-CUMYL-PINACA; SGT-25); and (1-(4- fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)m ethanone (trivial name: FUB-144), and their optical, positional, and geometric isomers, salts, and salts of isomers. The schedule I status of 5F-EDMB- PINACA, 5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA and FUB-144 currently is in effect until April 16, 2021. This temporary order will extend the temporary scheduling of 5F-EDMB-PINACA, 5F-MDMB-PICA, FUB-AKB48, 5F- CUMYL-PINACA and FUB-144 for one year or until the permanent scheduling action for these substances is completed, whichever occurs first.
Schedules of Controlled Substances: Placement of 5F-EDMB-PINACA, 5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA and FUB-144 in Schedule I
Document Number: 2021-06553
Type: Proposed Rule
Date: 2021-03-30
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration proposes placing ethyl 2- (1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbu tanoate (trivial name: 5F-EDMB-PINACA); methyl 2-(1-(5-fluoropentyl)-1H-indole- 3-carboxamido)-3,3-dimethylbutanoate (trivial name: 5F-MDMB-PICA); N- (adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (trivial names: FUB-AKB48; FUB-APINACA; AKB48 N-(4-fluorobenzyl)); 1-(5- fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxami de (trivial names: 5F-CUMYL-PINACA; SGT-25); and (1-(4-fluorobenzyl)-1H- indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (trivial name: FUB-144), including their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, in schedule I of the Controlled Substances Act. If finalized, this action would make permanent the existing regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle 5F-EDMB- PINACA, 5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA and FUB-144.
Designation of Methyl alpha-phenylacetoacetate, a Precursor Chemical Used in the Illicit Manufacture of Phenylacetone, Methamphetamine, and Amphetamine, as a List I Chemical
Document Number: 2021-05346
Type: Proposed Rule
Date: 2021-03-30
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration is proposing the control of the chemical methyl alpha-phenylacetoacetate (also known as MAPA; methyl 3-oxo-2-phenylbutanoate; methyl 2-phenylacetoacetate; [alpha]- acetyl-benzeneacetic acid, methyl ester; and CAS Number: 16648-44-5) and its optical isomers as a list I chemical under the Controlled Substances Act (CSA). Methyl alpha-phenylacetoacetate is used in clandestine laboratories to illicitly manufacture the schedule II controlled substances phenylacetone (also known as phenyl-2-propanone or P2P), methamphetamine, and amphetamine and is important to the manufacture of these controlled substances. If finalized, this action would subject handlers of methyl alpha-phenylacetoacetate to the chemical regulatory provisions of the CSA and its implementing regulations. This rulemaking does not establish a threshold for domestic and international transactions of methyl alpha- phenylacetoacetate. As such, all transactions of chemical mixtures containing methyl alpha-phenylacetoacetate would be regulated at any concentration and would be subject to control under the CSA.
Bulk Manufacturer of Controlled Substances Application: Bulk Manufacturer of Marihuana: MMJ 95, LLC
Document Number: 2021-06257
Type: Notice
Date: 2021-03-26
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) is providing notice of an application it has received from an entity applying to be registered to manufacture in bulk basic class(es) of controlled substances listed in schedule I. DEA intends to evaluate this and other pending applications according to its regulations governing the program of growing marihuana for scientific and medical research under DEA registration.
Importer of Controlled Substances Application: Shertech Laboratories, LLC
Document Number: 2021-06031
Type: Notice
Date: 2021-03-24
Agency: Drug Enforcement Administration, Department of Justice
Shertech Laboratories, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.
Importer of Controlled Substances Application: Medi-Physics Inc dba GE Healthcare
Document Number: 2021-06030
Type: Notice
Date: 2021-03-24
Agency: Drug Enforcement Administration, Department of Justice
Medi-Physics Inc dba GE Healthcare has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.
Importer of Controlled Substances Application: Perkinelmer, Inc.
Document Number: 2021-06029
Type: Notice
Date: 2021-03-24
Agency: Drug Enforcement Administration, Department of Justice
Perkinelmer, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.
Lawrence E. Stewart; Decision and Order
Document Number: 2021-05845
Type: Notice
Date: 2021-03-22
Agency: Drug Enforcement Administration, Department of Justice
Schedules of Controlled Substances: Placement of Four Specific Fentanyl-Related Substances in Schedule I
Document Number: 2021-05589
Type: Proposed Rule
Date: 2021-03-18
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration proposes placing ethyl (1- phenethylpiperidin-4-yl)(phenyl)carbamate (fentanyl carbamate), N-(2- fluorophenyl)-N-(1-phenethylpiperidin-4-yl)acrylamide (ortho- fluoroacryl fentanyl), N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4- yl)isobutyramide (ortho-fluoroisobutyryl fentanyl), and N-(4- fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamid e (para- fluoro furanyl fentanyl), including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, in schedule I of the Controlled Substances Act. These four specific substances fall within the definition of fentanyl-related substances set forth in the February 6, 2018, temporary scheduling order. Through the Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act, which became law on February 6, 2020, Congress extended the temporary control of fentanyl-related substances until May 6, 2021. If finalized, this action would make permanent the existing regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle fentanyl carbamate, ortho-fluoroacryl fentanyl, ortho-fluoro isobutyryl fentanyl, and para-fluoro furanyl fentanyl.
Bulk Manufacturer of Controlled Substances Application: Noramco Coventry, LLC.
Document Number: 2021-05582
Type: Notice
Date: 2021-03-18
Agency: Drug Enforcement Administration, Department of Justice
Noramco Coventry, LLC. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Cambridge Isotope Lab; Correction
Document Number: 2021-05358
Type: Notice
Date: 2021-03-16
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) published a document in the Federal Register of September 14, 2020, concerning a notice of application. The document contained a misspelling (Isotype vs. Isotope).
Importer of Controlled Substances Application: Purisys, LLC
Document Number: 2021-05356
Type: Notice
Date: 2021-03-16
Agency: Drug Enforcement Administration, Department of Justice
Purisys, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Bulk Manufacturer of Marihuana: Groff NA Hemplex LLC
Document Number: 2021-04810
Type: Notice
Date: 2021-03-09
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) is providing notice of an application it has received from an entity applying to be registered to manufacture in bulk basic class(es) of controlled substances listed in schedule I. DEA intends to evaluate this and other pending applications according to its regulations governing the program of growing marihuana for scientific and medical research under DEA registration.
Bulk Manufacturer of Controlled Substances Application: Patheon Pharmaceuticals Inc
Document Number: 2021-04809
Type: Notice
Date: 2021-03-09
Agency: Drug Enforcement Administration, Department of Justice
Patheon Pharmaceuticals Inc has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.